Recurrent and/or metastatic thyroid cancer: therapeutic options.
Thyroid cancer is relatively rare, accounting for 0.5 - 10 cases per 100,000 individuals per year. Despite their generally favourable prognosis, patients with differentiated thyroid cancer are at risk of tumour recurrence for decades after diagnosis. The optimal management remains controversial even...
Հիմնական հեղինակներ: | Karavitaki, N, Vlassopoulou, V, Tzanela, M, Tzavara, I, Thalassinos, N |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2002
|
Նմանատիպ նյութեր
-
Molecular staging using qualitative RT-PCR analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy.
: Karavitaki, N, և այլն
Հրապարակվել է: (2005) -
Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
: Tzanela, M, և այլն
Հրապարակվել է: (2004) -
Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
: Tzanela, M, և այլն
Հրապարակվել է: (2005) -
Novel therapeutic options for recurrent metastatic salivary gland tumors: Review of ongoing clinical trials
: Avinash Pandey, և այլն
Հրապարակվել է: (2018-01-01) -
THERAPEUTIC OPTIONS FOR INVASIVE BREAST CANCER
: Ganusevich O. N., և այլն
Հրապարակվել է: (2019-05-01)